Table 2.
Basic characteristics of the study population
|
Characteristic |
Total |
|---|---|
| (mean ± SD); n (%) | N=2485 |
| Age(years) |
59.2±10.6 |
| BMI, kg/m2 |
28.9±4.9 |
| Waist/hip ratio |
0.9±0.1 |
| Total cholesterol (TC) mmol/L |
5.8±1.2 |
| Low density lipoprotein cholesterol (LDL-C) mmol/L |
3.5±1.08 |
| High density lipoprotein cholesterol (HDL-C) mmol/L |
1.5±0.4 |
| Fasting blood glucose (FBG) mmol/L |
6.0±2.3 |
| Triglyceride (TG) mmol/L |
1.9±1.4 |
| Systolic blood pressure (SBP) mmHg |
131.4±17.0 |
| Diastolic blood pressure (DBP) mmHg |
80.7±9.2 |
| Serum uric acid (SUA) μmol/L |
287.7±99.5 |
| Smoking, n (%) |
539 (22.4%) |
| Physically active, n (%) |
1254 (56.0%) |
| Hyperuricemia, n (%) |
240 (10.7%) |
| Prehypertension (PreHT), n (%) |
595 (26.6%) |
| Prediabetes(PreDM), n (%) |
729 (32.5%) |
| Alopurinol use, n (%) | 64 (2.9%) |
Smoking – actual smoking or less than 6 months since quitting.
Physically active – at least 150 min/week moderate to vigorous physical activity.
Hyperuricemia (≥ 420 μmol/L men, ≥ 360 μmol/L women).
Prehypertension PreHT (SBP 120–139 mmHg and/or DBP 80–89 mmHg).
Prediabetes PreDM (fasting blood glucose 5.6–6.9 mmol/L).